Credit Suisse Ag Moderna, Inc. Put Options Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $14.4 Million - $23.5 Million	63,700 Added 14.12%	514,800 $131 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $66.2 Million - $145 Million	-298,500 Reduced 39.82%	451,100 $174 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $11.3 Million - $20.4 Million	86,800 Added 13.1%	749,600 $176 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $52.9 Million - $90.1 Million	-484,700 Reduced 42.24%	662,800 $86.8 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $598,234 - $1.55 Million	-9,100 Reduced 0.79%	1,147,500 $120 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $61.1 Million - $107 Million	1,123,800 Added 3426.22%	1,156,600 $81.8 Million
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $973,176 - $2.62 Million	32,800 New	32,800 $2.11 Million

1,114

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $24.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.